IGI Logo

"The pharmaceutical and healthcare sectors are expected to grow significantly due to rising demand, continued infrastructure development, supporting regulations, improved knowledge of preventative healthcare, and technological improvements. In this regard, it is anticipated that the Union Budget 2025 will establish a favourable framework with measures that promote affordability, increase market accessibility, and stimulate innovation.

In addition to boosting economic growth, India's path towards healthcare delivery self-reliance and its rise as a global pharmaceutical leader would strengthen the country's place in the global value chain. An increase in the health budget is anticipated in order to expand infrastructure and provide healthcare coverage to more people.

A uniform tax structure for the healthcare sector, coupled with support for research, innovation, and export incentives, is essential. With India's nutraceutical market poised for significant growth, these steps can boost global competitiveness and drive the sector's overall development.

In order to guarantee better healthcare outcomes across the country, the budget should also look at implementing broad-based production-linked incentive (PLI) programs to increase export competitiveness for the pharmaceutical industry.

Together, these actions will create a more robust and resilient healthcare system in India, supporting the country's long-term objectives for social and economic advancement."